SAC Capital

Broker's Calls

SAC Capital starts Hyphens Pharma on 'buy' as healthcare spending expected to rise

SINGAPORE (Nov 8): SAC Capital has initiated coverage on Hyphens Pharma International, a specialty pharmaceutical and consumer healthcare group, with a “buy” rating and target price of 28.5 cents.

M&A

Oxley raises stake in UE to 10.43% despite saying no counter bid

SINGAPORE (Aug 17): CEO Ching Chiat Kwong of Oxley Holdings has continued scooping up shares of United Engineers despite saying he does not plan to make a competing offer.

Broker's Calls

Lim & Tan expects takeover bid to fail, keeps United Engineers at ‘hold’

SINGAPORE (Aug 16): Lim & Tan Securities is maintaining its “hold” recommendation on United Engineers as it does not expect the takeover offer to succeed.
  •  
×